Pharmaceutical Commerce
Pharmaceutical Commerce - October 2025
Volume: 20
Issue: 5
Pharmaceutical Commerce - August 2025
Volume: 20
Issue: 4
Pharmaceutical Commerce - June 2025
Volume: 20
Issue: 3
Pharmaceutical Commerce - April 2025
Volume: 20
Issue: 2
Pharmaceutical Commerce - February 2025
Volume: 20
Issue: 1
Pharmaceutical Commerce - December 2024
Volume: 19
Issue: 6
Pharmaceutical Commerce - October 2024
Volume: 19
Issue: 5
Pharmaceutical Commerce - August 2024
Volume: 19
Issue: 4
Pharmaceutical Commerce - June 2024
Volume: 19
Issue: 3
Pharmaceutical Commerce - April 2024
Volume: 19
Issue: 2
Pharmaceutical Commerce - February 2024
Volume: 19
Issue: 1
Pharmaceutical Commerce - December 2023
Volume: 18
Issue: 6
Pharmaceutical Commerce - October 2023
Volume: 18
Issue: 5
Pharmaceutical Commerce - August 2023
Volume: 18
Issue: 4
Pharmaceutical Commerce - June 2023
Volume: 18
Issue: 3
Pharmaceutical Commerce - April 2023
Volume: 18
Issue: 2
Pharmaceutical Commerce - February 2023
Volume: 18
Issue: 1
Pharmaceutical Commerce - December 2022
Volume: 17
Issue: 6
Pharmaceutical Commerce - October 2022
Volume: 17
Issue: 5
Pharmaceutical Commerce - August 2022
Volume: 17
Issue: 4
Pharmaceutical Commerce - June 2022
Volume: 17
Issue: 3
Pharmaceutical Commerce - April 2022
Volume: 17
Issue: 2
Pharmaceutical Commerce - February 2022
Volume: 17
Issue: 1
Pharmaceutical Commerce - November 2021
Volume: 16
Issue: 4
Pharmaceutical Commerce - September 2021
Volume: 16
Issue: 3
Pharmaceutical Commerce - June 2021
Volume: 16
Issue: 2
Pharmaceutical Commerce - March 2021
Volume: 16
Issue: 1
Pharmaceutical Commerce - December 2020
Volume: 15
Issue: 4
Pharmaceutical Commerce - September 2020
Volume: 15
Issue: 3
Pharmaceutical Commerce - June 2020
Volume: 15
Issue: 2
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cambrex Commits $120 Million to Grow US API Manufacturing
2
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
3
How Biopharma Companies Can Optimize Field Reimbursement Models
4
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
5
